Alison Luckey, MD

Global Antibiotic R&D Partnership (GARDP), Switzerland

Disclosure(s): GARDP: Employee of GARDP, a non-profit Swiss-based foundation, which receives government and private-funded institutional grants/research support

Poster(s):

• (P-1103) In Vitro Activity of Zoliflodacin Against Baseline Neisseria gonorrhoeae Isolates from US Participants in a Global Phase 3 Randomized Controlled Trial
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1251) Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT